Login
Products
Login
Home
Alerts
Search
Watchlist
Products

Dai-ichi Karkaria Ltd

DAICHI
BSE
265.20
2.06%
Last Updated:
29 Apr '26, 4:00 PM
Company Overview
Alert
Watchlist
Note

Dai-ichi Karkaria Ltd

DAICHI
BSE
265.20
2.06%
29 Apr '26, 4:00 PM
Company Overview
Add Alert
Add to Watchlist
Edit Note
6M
Price
Charts
Documents

Quick Ratios

Edit Ratios
Mkt Cap
Market Capitalization
198Cr
Close
Close Price
265.20
Industry
Industry
Chemicals - Speciality
PE
Price To Earnings
36.78
PS
Price To Sales
1.04
Revenue
Revenue
190Cr
Rev Gr TTM
Revenue Growth TTM
31.36%
PAT Gr TTM
PAT Growth TTM
12.78%
Peer Comparison
How does DAICHI stack up?
Compare up to 10 companies side by side across valuation, profitability, and growth.
DAICHI
VS

Quarterly Results

Consolidated
Standalone
Numbers
Percentage
QuarterMar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025
Revenue
RevenueCr
422835353334374170394338
Growth YoY
Revenue Growth YoY%
35.8-27.2-35.5-27.8-21.321.54.815.4109.816.516.4-7.1
Expenses
ExpensesCr
372833333132353862384138
Operating Profit
Operating ProfitCr
5-12232238120
OPM
OPM%
12.0-2.14.77.08.35.74.76.711.53.24.2-0.8
Other Income
Other IncomeCr
1121111131121
Interest Expense
Interest ExpenseCr
111000100000
Depreciation
DepreciationCr
222222333333
PBT
PBTCr
3-320010037-11-2
Tax
TaxCr
40500001201-1
PAT
PATCr
0-315110025-10-2
Growth YoY
PAT Growth YoY%
74.7-29.221.4-93.4317.490.8-102.5223.7391.0-88.98.1-178.5
NPM
NPM%
-1.1-10.542.31.73.0-0.8-1.04.77.0-1.3-0.8-4.0
EPS
EPS
0.8-3.919.61.51.50.6-0.33.58.30.00.0-1.1

Profit & Loss

Consolidated
Standalone
Numbers
Percentage
Financial YearMar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025TTM
Revenue
RevenueCr
1811941261479210797122184132181190
Growth
Revenue Growth%
22.87.1-35.016.6-37.116.1-9.125.151.0-28.537.94.8
Expenses
ExpensesCr
159162109132103112111140168125167179
Operating Profit
Operating ProfitCr
22321715-11-5-14-181661411
OPM
OPM%
12.216.613.910.4-11.7-4.7-13.9-15.18.64.88.05.7
Other Income
Other IncomeCr
15412620878172465
Interest Expense
Interest ExpenseCr
0000710913321
Depreciation
DepreciationCr
52248997791010
PBT
PBTCr
32342716-24-2556-18221884
Tax
TaxCr
91274-120704522
PAT
PATCr
23222112-13-2548-18181363
Growth
PAT Growth%
49.2-6.1-4.5-42.6-205.4-97.5294.2-137.7201.1-27.0-54.2-58.6
NPM
NPM%
12.911.316.68.2-13.7-23.349.7-15.010.010.33.41.4
EPS
EPS
31.329.333.418.4-16.9-30.868.0-24.226.918.612.17.2

Balance Sheet

Consolidated
Standalone
Numbers
Percentage
Financial YearMar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Sep 2025
Equity Capital
Equity CapitalCr
777777777777
Reserves
ReservesCr
101119142151135112163142162173181178
Current Liabilities
Current LiabilitiesCr
363023546480665858394237
Non Current Liabilities
Non Current LiabilitiesCr
3266375702720333
Total Liabilities
Total LiabilitiesCr
147159179276281270239214247222232225
Current Assets
Current AssetsCr
108106911007274936868537068
Non Current Assets
Non Current AssetsCr
395488176209196146146179169162157
Total Assets
Total AssetsCr
147159179276281270239214247222232225

Cash Flow

Consolidated
Standalone
Financial YearMar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Operating Cash Flow
Operating Cash FlowCr
5113-861-22-3231016
Investing Cash Flow
Investing Cash FlowCr
0-8-7-57-211130-4-3316-4
Financing Cash Flow
Financing Cash FlowCr
-3-626616-6-97-213-25-10
Net Cash Flow
Net Cash FlowCr
3-3-222-411-10413
Free Cash Flow
Free Cash FlowCr
-90-19-90-32-1109-14-10514
CFO To PAT
CFO To PAT%
23.450.312.4-64.9-49.3-3.9-44.518.7125.574.6260.8
CFO To EBITDA
CFO To EBITDA%
24.734.314.9-51.0-57.5-18.9159.018.6145.9159.9111.5

Ratios

Consolidated
Standalone
Financial YearMar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Valuation Ratios
Valuation Ratios
Market Cap
Market CapitalizationCr
117260370295153130222272270380177
Price To Earnings
Price To Earnings
5.112.814.821.60.00.04.40.013.427.419.7
Price To Sales
Price To Sales
0.71.32.92.01.71.22.32.21.52.91.0
Price To Book
Price To Book
1.12.12.51.91.11.11.31.81.62.10.9
EV To EBITDA
EV To EBITDA
4.87.821.123.5-21.6-42.9-16.7-15.718.962.512.4
Profitability Ratios
Profitability Ratios
GPM
GPM%
37.041.139.535.531.333.330.926.835.640.335.8
OPM
OPM%
12.216.613.910.4-11.7-4.7-13.9-15.18.64.88.0
NPM
NPM%
12.911.316.68.2-13.7-23.349.7-15.010.010.33.4
ROCE
ROCE%
29.926.718.07.2-7.5-7.034.1-9.812.110.75.1
ROE
ROE%
21.517.313.97.5-8.8-20.828.4-12.210.97.53.3
ROA
ROA%
15.813.711.74.3-4.5-9.220.3-8.57.56.12.7
Operational Ratios
Operational Ratios
Solvency Ratios
Solvency Ratios
Liquidity Ratios
Liquidity Ratios
Dai-ichi Karkaria Limited is a pioneering Indian specialty chemical manufacturer established in **1963** in technical collaboration with **Dai-ichi Kogyo Seiyaku (Japan)**. The company has evolved into a high-performance entity focused on custom formulations and specialty surfactants. Operating as a single-segment entity, it leverages deep technical expertise to serve critical industrial sectors including Energy, Agrochemicals, and Personal Care. --- ### **Strategic Manufacturing Infrastructure & Capacity Expansion** The company’s operational backbone consists of two primary manufacturing sites and a corporate headquarters in **Mumbai**. Following a period of reconstruction after a major fire in 2020, the company has transitioned into a phase of aggressive capacity restoration and modernization. | Facility | Location | Strategic Focus & Recent Developments | | :--- | :--- | :--- | | **Dahej Plant** | Bharuch, Gujarat | Primary site for **Ethoxylation** and **PPD** (Pour Point Depressants). Recently modified into a **multi-purpose plant** to mitigate cyclicality. | | **Kurkumbh Plant** | Pune, Maharashtra | Focuses on specialty formulations; maintains a stable workforce of **178 employees**. | * **Ethoxylation De-bottlenecking:** The Ethoxylation unit is currently operating at **100% capacity**. To address this, a new reactor is under installation and scheduled for commissioning in **FY 2026-27**. * **The EOPO Project:** Engineering work has commenced on the **EOPO (Ethylene Oxide/Propylene Oxide)** project, a long-term growth initiative designed to broaden the product portfolio. * **Operational Efficiency:** The company has achieved a **50% reduction** in lab turnaround times for high-volume products and significant reductions in batch cycle times through data-driven process enhancements and the installation of new raw material storage tanks. --- ### **Core Business Verticals & Market Applications** The company’s business model is centered on **customer-driven innovation**, with a portfolio characterized by tailor-made solutions transitioned from lab to commercial scale within a **90-day window**. * **Energy & Oilfield (Strategic Core):** Produces **PPDs**, **VII** (Viscosity Index Improvers), and **H2S Scavengers**. Despite temporary tender fluctuations in **2026**, this remains a primary growth driver, particularly in the **Middle East and North Africa**. * **Agrochemicals:** Provides emulsifiers and dispersing agents for **SC, WDG, and OD** formulations. This segment achieved **50% sales growth** in **FY 2024-25**, driven by a shift toward water-based and powder-grade surfactants. * **Home & Personal Care:** Offers biodegradable surfactants and **EO-free** emulsifiers. Volume growth exceeded **35%** in **FY 2023-24**, led by oleoresin solubilizers meeting stringent global purity standards. * **Paints, Pigments & Coatings:** Supplies **APEO-free** emulsifiers and pigment stabilizers. This vertical saw **20% volume growth** in **FY 2024-25**, supplying nearly all major Indian emulsion units. * **Emerging Frontiers:** The company is actively researching product development for **Electric Vehicles (EVs) and batteries** to capitalize on the global energy transition. --- ### **Research, Development & Sustainability** Innovation is the primary driver of the company’s longevity, with **R&D expenditure** ranging between **0.80% and 1.41% of turnover** (**₹2.29 crore** recurring). * **Technical Capabilities:** Expertise in scaling complex chemical syntheses for extreme operating environments, particularly in the upstream oil sector. * **Digital Transformation:** Implementation of **AI models** for predictive maintenance and production data analysis to optimize yields. * **Green Chemistry:** Focus on **"Goal Zero"** for effluents and developing low-VOC, biodegradable alternatives. * **Environmental Tech:** Utilizes **Submersible Ultra-Filtration (SUF)** and closed-loop vacuum systems to reduce water consumption by **2,100 KL/month**. The company holds **ISO 14001:2018** and **ISO 45001:2018** certifications. --- ### **Financial Performance & Capital Structure** The company demonstrated a significant turnaround in **FY 2024-25**, characterized by a **38% revenue increase** and a return to a **debt-free balance sheet** (excluding working capital). **Consolidated Financial Summary:** | Metric | FY 2024-25 | FY 2023-24 | Growth (%) | | :--- | :--- | :--- | :--- | | **Revenue from Operations** | **₹ 181.4 crore** | **₹ 131.6 crore** | **38%** | | **EBITDA** | **₹ 18.92 crore** | **₹ 12.56 crore** | **50.6%** | | **Profit Before Tax (PBT)** | **₹ 6.9 crore** | **Marginal** | **N/A** | | **Gross Margin** | **36%** | **36%** | **Steady** | **Liquidity & Debt Position (as of March 31, 2025):** * **Adjusted Net Debt:** Reduced to **₹3.96 crore** from **₹12.64 crore** year-on-year. * **Net Debt to Equity Ratio:** Improved to **0.02**. * **Credit Rating:** Upgraded by **CRISIL** in July 2025 to **BBB-/Stable**, though the company later voluntarily withdrew ratings in **April 2026** as sanctioned limits fell below external rating requirements. * **Foreign Exchange:** Strong net earner with **₹54.84 crore** in earnings against **₹8.78 crore** in outgo (FY24). --- ### **Corporate Structure & Strategic Alliances** The company operates through a network of subsidiaries and high-value partnerships: * **Subsidiary:** **Dai-ichi Gosei Chemicals (India) Limited**. * **Joint Venture:** **ChampionX Dai-ichi India Private Limited (CXDI)**, a **50:50** JV with **ChampionX Corporation, USA**. The company supplies up to **₹50 Crores** of raw materials annually to this JV. * **Related Party Sourcing:** Procurement arrangement with **Indian Oxides and Chemicals Private Limited (IOCL)** for up to **₹50 Crores**. **Leadership Succession (Effective April 1, 2026):** * **Ms. Meher Vakil Taff:** Transitioning to **Vice-Chairperson, CEO, and Managing Director**. * **Mrs. Shernaz Vakil:** Continuing as **Chairperson & Whole-time Director** (forgoing FY27 incentives). --- ### **Risk Factors & Mitigation** * **Market Competition:** Facing "throw-away prices" and dumping from **Chinese manufacturers** with excess capacity. The company mitigates this through the **"China + 1" strategy** and focusing on high-contribution specialty niches. * **Macroeconomic Headwinds:** Sluggish demand in **Europe and the US** due to inflation and recessionary pressures. * **Regulatory & Legal:** * Ongoing appeals against a **₹2.17 crore CGST order** and income tax assessments for **AY 2024-25**. * Non-recurring impact of **₹20 lakhs** in **Q3 FY 2026** due to new **Labour Code** implementations. * **Historical Recovery:** The **2020 Dahej fire** resulted in a **₹49.32 crore** loss; however, the final insurance settlement of **₹20.58 crore** (received Sept 2023) and the completion of the new plant have stabilized operations.